We often see a reduction in symptoms and an improvement in daily functioning among those who have had a fairly dramatic weight loss through dieting, exercise, and sometimes bariatric surgery, says Dennis Bourdette, MD, FAAN, professor emeritus of neurology at Oregon Health & Science University in Portland
Without balancing hormones, GLP-1 medications may not work as effectively
Rule: do not crown amycretin the winner because an early 22% mean looks higher than a Phase 3 20% mean from a different design
This is where supplementation becomes particularly valuable
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
Contraindications Pregnancy and breastfeeding represent absolute contraindications due to BPC-157s cell proliferative effects and lack of safety data in these populations